gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · AHealthcareLab Analytical Instruments

Agilent Technologies Inc. (A)

$177.17+0.97%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$177.17▲ 21.28% in range
Nov 4, 2025Low $110.24 · High $181.48Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Agilent Technologies closed at $177.17 on Nov 4, up 0.97%, 2.4% below its 52-week closing high. Volume of 1.6M shares was 0.78× its 20-day average (below normal).

Split-adjusted performance: +4.6% over one month, +50.5% over six months, +22.4% over one year.

In the quarter ended Jul 31, 2026, revenue was $1.88B, up 8.1% from a year earlier, with a net margin of 19.3%.

Short interest was 5.0M shares at the Oct 15 settlement, down 4.1% from the prior report (1.8% of float, 2.4 days to cover).

Market cap$49.95B281.9M shares
Revenue · quarter$1.88B+8.1% YoY
Diluted EPS$1.28+8.5% YoY
P/E · TTM34.7×P/S 6.8×
Net margin19.3%Gross 55.5%
Dividend yield0.58%$0.255 last paid
52-week range110.24 – 181.48−2.4% from high
Volume1.6M0.78× 20-day avg
Volatility · 60d29.1%Annualised
Short % of float1.8%2.4 days to cover
Net cash-$2.19BCash $1.76B
Next earnings—Not scheduled
Split-adjusted performance
1W −2.4%1M +4.6%3M +25.4%6M +50.5%YTD +30.2%1Y +22.4%3Y +75.1%5Y +14.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Lab Analytical Instruments

Percentile among 22 companies (100 = best)

6-month momentum70
Revenue growth63
Net margin86
Value (low P/E)—
Size100

Industry medians: 6-month return +33.8%, revenue growth +4.9%, net margin −19.0%, P/E 38.3×.

Short interest

Details →
Shares short5.0M−4.1% vs prior
Days to cover2.4Settled Oct 15
% of float1.8%
Short vol. 10d49.8%of daily volume

Closest peers by size in Lab Analytical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
AAgilent Technologies$177.17+0.97%+50.5%+8.1%19.3%34.7$49.95B
WATWaters$467.60+1.67%+33.8%+113.4%−8.3%276.5$45.94BCompare
MTDMettler-Toledo International$1,723.24+1.48%+29.9%+4.5%22.7%38.1$34.53BCompare
ILMNIllumina$226.54−4.90%+58.9%+4.2%19.5%38.3$34.25BCompare
RVTYRevvity$159.43−2.48%+60.9%+1.3%7.1%74.9$17.79BCompare
AVTRAvantor$15.65+0.38%+85.6%+4.6%12.0%31.4$10.60BCompare
BIOBio-Rad Laboratories$379.99+1.35%+46.7%−0.1%57.1%45.7$10.16BCompare
BIO.BBio-Rad Laboratories$379.50+4.22%—−0.1%57.1%45.6$10.15BCompare
BRKRBruker$63.79+12.90%+50.8%+5.2%−7.5%—$9.72BCompare

News about Agilent Technologies

All news →
Thailand Next Generation Sequencing (NGS) Market Size, Share, Trends, and Forecast - 2026 to 2036 | Precision Medicine Drives 12.7% CAGR and a $305.21 Million OpportunityGlobeNewswire Inc. · Oct 28, 2026▲ PositiveIf You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth NowZacks Investment Research · Sep 23, 2026▲ PositiveInternational Markets and Agilent (A): A Deep Dive for InvestorsZacks Investment Research · Aug 31, 2026NeutralLaboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS InsiderGlobeNewswire Inc. · Aug 27, 2026▲ Positive[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)GlobeNewswire Inc. · Aug 6, 2026▲ Positive

Quick answers

What does Agilent Technologies do?
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets.
What is A's market cap?
$49.95B, based on the Nov 4 close of $177.17.
What is A's P/E ratio?
34.7× trailing-twelve-month earnings of $1.44B.
Does Agilent Technologies pay a dividend?
Yes. The latest regular dividend was $0.255 per share (ex-date Oct 6), an annualised yield of 0.58%.
How much of A is sold short?
5.0M shares, 1.8% of float, as of Oct 15, 2026.
What sector is A in?
Healthcare, in the Lab Analytical Instruments industry.

About Agilent Technologies

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

HQ: Santa Clara, CA18,200 employeesListed Nov 18, 1999agilent.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology